


SHORRER DORON Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      SHORRER DORON
                    

•   JERUSALEM, L3
                      
How do I update this listing?




                                             Shorrer Doron is based out of Jerusalem.    WhaleWisdom has at least 1 insider transactions (Form 3,4,5) in our database for Shorrer Doron. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from SHORRER DORON, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




shorrer doron


33 KOREH PLADORR ST

JERUSALEM
L3
                                                        
                                                    93393


                                                      Business Phone:
                                                      972-74-710-7171
SEC SIC CODE:2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)







Recent SEC Filings




4 filed on 12/29/2016
4 filed on 06/06/2016
4 filed on 02/17/2016
4 filed on 01/07/2016
4 filed on 01/08/2015
4 filed on 12/26/2013
4 filed on 06/27/2013
4 filed on 12/22/2011
4 filed on 05/19/2011
4 filed on 12/07/2010
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free




















		Doron Shorrer - Pluristem Therapeutics Inc.  Pluristem Therapeutics Inc.	













































Pluristem Therapeutics Inc.







Company
Products 

PLX Products
Pipeline – PLX-PAD

Critical Limb Ischemia
Intermittent Claudication
Orthopedic Indications
Pulmonary Arterial Hypertension
Women’s Health


Pipeline – PLX-R18

Hematology
Acute Radiation Syndrome




Clinical Programs 

Clinical Development Strategy
Critical Limb Ischemia (CLI)
Intermittent Claudication (IC)
Muscle Injury
Acute Radiation Syndrome (ARS)
Hematopoietic cell Transplantation
Pulmonary Arterial Hypertension (PAH)


Science & Technology 

Mechanism of Action
3D Manufacturing Platform
Placenta
Intellectual Property
Additional Technologies
Preclinical Programs
Scientific Publications


Collaborations 

Partnering strategy
Industry Partners
Academic Partners


Investors & Media 

News
From the Media
Events
Presentations
Financial Statements
SEC Filing
Covering Analysts
Corporate Governance
IR Team





















Taboola's Blog













Doron Shorrer


Wednesday April 20th


by pluristemsiteadmin














Tweet















 



Mr. Doron Shorrer (CPA, Israel) was Chairman of the Board of Phoenix Insurance Company, one of the largest insurance companies in Israel and Mivtachim Pension Benefit Group, the largest pension fund in Israel, managing $15 billion. Before assuming these positions, Mr. Shorrer held senior appointments that included: Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the Board of Directors of “Nechasim” of the State of Israel; Member of the Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Co-Founder and Director of an accounting firm having three branches (Jerusalem, Tel-Aviv, Haifa); Member of the Lecture Staff of the Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy.
Among many areas of expertise, Mr. Shorrer formulates, implements and administers business planning in the private and institutional sector. Additionally, Mr. Shorrer consults on economic, accounting and taxation issues to a large audience, ranging from private concerns to government ministries. Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration, with a specialization in finance and banking from the Hebrew University of Jerusalem. He is a Certified Public Accountant (ISR).









































   Doron Shorrer | Shorrer International | ZoomInfo.com




EDGAR Filing Documents for 0001178913-10-003229







This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.


Home | Latest Filings | Previous Page




Search the Next-Generation EDGAR System
Filing Detail





SEC Home »
Search the Next-Generation EDGAR System »
Company Search »
Current Page








Form 4 - Statement of changes in beneficial ownership of securities: 
      

SEC Accession No. 0001178913-10-003229
      



Filing Date
2010-12-07
Accepted
2010-12-07 14:34:42
Documents
1


Period of Report
2010-12-07
Filing Date Changed
2010-12-07








Document Format Files


Seq
Description
Document
Type
Size


1

zk1009158.html
4
 


1

zk1009158.xml
4
3034


 
Complete submission text file
0001178913-10-003229.txt
 
5013







Mailing Address
      MATAM ADVANCED TECHNOLOGY PARK
BUILDING NO. 20

HAIFA L3 31905      

Business Address
      MATAM ADVANCED TECHNOLOGY PARK
BUILDING NO. 20

HAIFA L3 31905      
972-4-850-1080


PLURISTEM THERAPEUTICS INC (Issuer)
 CIK: 0001158780 (see all company filings)
IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630SIC: 2836 Biological Products, (No Diagnostic Substances)Assistant Director 1




Mailing Address
      33 KOREH PLADORR ST

JERUSALEM L3 93393      

Business Address
   

SHORRER DORON (Reporting)
 CIK: 0001268788 (see all company filings)
Type: 4 | Act: 34 | File No.: 001-31392 | Film No.: 101236728








PSTI Doron Shorrer Insider Trades for Pluristem Therapeutics Inc.


































X

Tweet
 

Share this bulletin

Get news bulletins by email

Bulletin

White House briefs reporters after Spicer quits as press secretary: live blog »
        




Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Pluristem Therapeutics Inc.

                  NASDAQ: PSTI
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Pluristem Therapeutics Inc.



Market open
 --Real time quotes
Jul 21, 2017, 2:03 p.m.


PSTI

/quotes/zigman/108591/composite


$
1.20




Change

+0.02
+1.69%

Volume
Volume 99,194
Real time quotes








/quotes/zigman/108591/composite
Previous close

$
			1.18
		


$
				1.20
			
Change

+0.02
+1.69%





Day low
Day high
$1.19
$1.25










52 week low
52 week high

            $1.04
        

            $1.85
        


















Insider Activity


Individual




Doron Shorrer



Mr. Doron Shorrer is a Director at Pimi Agro CleanTech, Inc., Independent Director at Pluristem Therapeutics, Inc., and Chairman & Chief Executive Officer at Shorrer International Ltd. He is on the Board of Directors at Pimi Agro CleanTech, Inc., Omer Insurance Cos., AIG Israel Insurance Co., Ltd., Pluristem Therapeutics, Inc., Bank Massad Ltd., Massad Bank ltd., and Pimi Agro CleanTech Ltd.
Mr. Shorrer was previously employed as Chairman by Israel Phoenix Insurance Co., Chairman by Lito Group Ltd., and Deputy Chairman by Opal Balance Investments Ltd. He also served on the board at B. Yair Building Corp. Ltd.
He received his undergraduate degree from The Hebrew University of Jerusalem and a graduate degree from The Hebrew University of Jerusalem.



Transactions


Date
Shares
Transaction
Value





12/29/2016
66,500


 
Award at $0 per share.


0


05/30/2016
12,346


 
Disposition at $1.52 per share.


18,766


02/15/2016
12,346


 
Acquisition at $0.81 per share.


10,000


01/05/2016
49,000


 
Award at $0 per share.


0


01/08/2015
49,000


 
Award at $0 per share.


0


12/26/2013
50,000


 
Award at $0 per share.


0


06/27/2013
85,000


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Zami  Aberman 
Chairman & Co-Chief Executive Officer




Mr. Yaky  Yanay 
President, Co-Chief Executive Officer & Director




Mr. Erez  Egozi 
Chief Financial Officer & Treasurer




Dr. Esther  Lukasiewicz-Hagai 
Vice President-Clinical & Medical Affairs




Dr. Racheli  Ofir 
Vice President-Research & Intellectual Property




Dr. Hillit Mannor Shachar 
Vice President-Business Development




Dr. Moria  Kwiat 
Director




Ms. Hava Klemperer Meretzki 
Director




Mr. Isaac  Braun 
Director




Mr. Mark S. Germain 
Director




Mr. Efrat  Kaduri 
Manager-Investor & Public Relations




Ms. Karine  Kleinhaus 
Vice President-North America Division & IR Contact




Ms. Efrat  Livne-Hadass 
Vice President-Human Resources




Mr. Doron  Shorrer 
Independent Director




Mr. Israel  Ben-Yoram 
Independent Director




Mr. Nachum  Rosman 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/65801738/composite TLT+1.11%


/quotes/zigman/59386294/composite JNUG-5.94%


X




Powered by














Log In




2:11 PM EDT
July 21, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
2:10pGold logs highest finish in a month, up over 2% for the week 
2:10pMicrosoft is challenging Amazon for cloud throne
2:10pAm I entitled to a spousal benefit?
2:10pWhite House briefs reporters after Spicer quits as press secretary: live blog
2:07pNot even free money can make some people go to the gym 
2:07p10 seriously inappropriate things you should never (ever) say to a co-worker
2:06pWant to buy happiness? Splurge on these 5 things
2:05pNote to parents: This social network was rated the worst for teenage cyberbullying
2:05pPreserving a fruitful retirement
2:04pThis is the deadliest time of your life to put on weight
2:03pThe dark side of cruises
2:03p5 reasons why millennials can’t have nice things (or save any money)
2:03pWhat Eleanor Roosevelt and Helen Gurley Brown ate — and what we can learn from it 
2:03p7 money-making lessons from the richest man who ever lived
2:03p‘Property Brothers’ is inspiring homeowners to remodel — but creating fictional expectations about how much it costs
2:01pThis week’s retirement news
2:01pHollywood is using social causes to sell movie tickets 
1:49pGold marks highest settlement in a month, up over 2% for the week
1:48pSpicer says in a tweet he'll continue in job through August
1:43pGold prices end at highest level in a month, up over 2% for the week
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,562.25

-49.53
-0.23%





nasdaq

/quotes/zigman/12633936/realtime
6,380.83

-9.17
-0.14%





s&p 500

/quotes/zigman/3870025/realtime
2,470.31

-3.14
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15



























































Doron Shorer |  | Decypha

































Sign In
|
Welcome  Guest 









 







Regions

GCC
                                |
                                    Levant
                                |
                                    MENA
                                |
                                    North Africa




GCC

Bahrain
                            |
                            Kuwait
                            |
                            Oman
                            |
                            Qatar
                            |
                            Saudi Arabia
                            |
                            United Arab Emirates




Levant

Iraq
                            |
                            Jordan
                            |
                            Lebanon
                            |
                            Palestine




North Africa

Egypt
                            |
                            Libya
                            |
                            Morocco
                            |
                            Tunisia




Others

Iran
                            |
                            Turkey
                            |
                            United Kingdom
                            |
                            United States












Advanced Search















News






Markets






Companies






Research






Funds






Fixed Income






Money Markets






Commodities






FX






Economics






Analysis






More











Sign In
Membership
Customize Your Decypha
Logout
Welcome
Decypha Alerts












Home




People Profiles




People Profile



Doron Shorer Profile














Full Name:

                                                    Doron Shorer
                                                







Country:











Biography


                                                    Mr. Shorrer became a director of the Company in October 2003.  Mr. Shorrer was one of the Company’s founders and served as its first Chairman until 2006.... 











Designations




Date
Designation
Entity
Entity Description
Country




2003


Pluristem Therapeutic

--

--









Check all the  individuals in 
Check The List






Request a Trial
















Title:*


Select
Mr
Mrs
Ms
Miss
Dr
Prof




First Name:*



Last Name:*



Job Title:*


Select
 Asset Managers
 Corporate Banks
 Investment Managers
 Wealth Managers
 Consultants & Advisors
 Legal Practioners
 Academics
 Hedge Funds
 Private Equity Analysts
 Traders
 Equity Research Analysts




Phone:*



Company:*




Email:*




Country:*


Select

                                                Afganistan
                                        

                                                Albania
                                        

                                                Algeria
                                        

                                                American Samoa
                                        

                                                Andorra
                                        

                                                Angola
                                        

                                                Anguilla
                                        

                                                Antarctica
                                        

                                                Antigua and Barbuda
                                        

                                                Argentina
                                        

                                                Armenia
                                        

                                                Aruba
                                        

                                                Australia
                                        

                                                Austria
                                        

                                                Azerbaijan
                                        

                                                Bahamas
                                        

                                                Bahrain
                                        

                                                Bangladesh
                                        

                                                Barbados
                                        

                                                Belarus
                                        

                                                Belgium
                                        

                                                Belize
                                        

                                                Benin
                                        

                                                Bermuda
                                        

                                                Bhutan
                                        

                                                Bolivia
                                        

                                                Bosnia and Herzegovina
                                        

                                                Botswana
                                        

                                                Bouvet Island
                                        

                                                Brazil
                                        

                                                British Indian Ocean Territory
                                        

                                                Brunei
                                        

                                                Bulgaria
                                        

                                                Burkina Faso
                                        

                                                Burundi
                                        

                                                Cambodia
                                        

                                                Cameroon
                                        

                                                Canada
                                        

                                                Cape Verde
                                        

                                                Cayman Islands
                                        

                                                Central African Republic
                                        

                                                Chad
                                        

                                                Chile
                                        

                                                China
                                        

                                                Christmas Island
                                        

                                                Cocos (Keeling) Islands
                                        

                                                Colombia
                                        

                                                Comoros
                                        

                                                Congo
                                        

                                                Cook Islands
                                        

                                                Costa Rica
                                        

                                                Cote D'Ivoire (Ivory Coast)
                                        

                                                Croatia (Hrvatska)
                                        

                                                Cuba
                                        

                                                Curacao
                                        

                                                Cyprus
                                        

                                                Czech Republic
                                        

                                                Czechoslovakia (former)
                                        

                                                Denmark
                                        

                                                Djibouti
                                        

                                                Dominica
                                        

                                                Dominican Republic
                                        

                                                East Timor
                                        

                                                Ecuador
                                        

                                                Egypt
                                        

                                                El Salvador
                                        

                                                Equatorial Guinea
                                        

                                                Eritrea
                                        

                                                Estonia
                                        

                                                Ethiopia
                                        

                                                Falkland Islands (Malvinas)
                                        

                                                Faroe Islands
                                        

                                                Fiji
                                        

                                                Finland
                                        

                                                France
                                        

                                                France, Metropolitan
                                        

                                                French Guiana
                                        

                                                French Polynesia
                                        

                                                French Southern Territories
                                        

                                                Gabon
                                        

                                                Gambia
                                        

                                                Georgia
                                        

                                                Germany
                                        

                                                Ghana
                                        

                                                Gibraltar
                                        

                                                Greece
                                        

                                                Greenland
                                        

                                                Grenada
                                        

                                                Guadeloupe
                                        

                                                Guam
                                        

                                                Guatemala
                                        

                                                Guernsey
                                        

                                                Guinea
                                        

                                                Guinea-Bissau
                                        

                                                Guyana
                                        

                                                Haiti
                                        

                                                Heard and McDonald Islands
                                        

                                                Honduras
                                        

                                                Hong Kong
                                        

                                                Hungary
                                        

                                                Iceland
                                        

                                                India
                                        

                                                Indonesia
                                        

                                                Iran
                                        

                                                Iraq
                                        

                                                Ireland
                                        

                                                Isle of Man
                                        

                                                Israel
                                        

                                                Italy
                                        

                                                Jamaica
                                        

                                                Japan
                                        

                                                Jersey
                                        

                                                Jordan
                                        

                                                Kazakhstan
                                        

                                                Kenya
                                        

                                                Kiribati
                                        

                                                Kuwait
                                        

                                                Kyrgyzstan
                                        

                                                Laos
                                        

                                                Latvia
                                        

                                                Lebanon
                                        

                                                Lesotho
                                        

                                                Liberia
                                        

                                                Libya
                                        

                                                Liechtenstein
                                        

                                                Lithuania
                                        

                                                Luxembourg
                                        

                                                Macau
                                        

                                                Macedonia
                                        

                                                Madagascar
                                        

                                                Malawi
                                        

                                                Malaysia
                                        

                                                Maldives
                                        

                                                Mali
                                        

                                                Malta
                                        

                                                Marshall Islands
                                        

                                                Martinique
                                        

                                                Mauritania
                                        

                                                Mauritius
                                        

                                                Mayotte
                                        

                                                Mexico
                                        

                                                Micronesia
                                        

                                                Moldova
                                        

                                                Monaco
                                        

                                                Mongolia
                                        

                                                Montenegro
                                        

                                                Montserrat
                                        

                                                Morocco
                                        

                                                Mozambique
                                        

                                                Myanmar
                                        

                                                Namibia
                                        

                                                Nauru
                                        

                                                Nepal
                                        

                                                Netherlands
                                        

                                                Netherlands Antilles
                                        

                                                Neutral Zone
                                        

                                                New Caledonia
                                        

                                                New Zealand (Aotearoa)
                                        

                                                Nicaragua
                                        

                                                Niger
                                        

                                                Nigeria
                                        

                                                Niue
                                        

                                                Norfolk Island
                                        

                                                North Korea
                                        

                                                Northern Mariana Islands
                                        

                                                Norway
                                        

                                                Oman
                                        

                                                Pakistan
                                        

                                                Palau
                                        

                                                Palestine
                                        

                                                Panama
                                        

                                                Papua New Guinea
                                        

                                                Paraguay
                                        

                                                Peru
                                        

                                                Philippines
                                        

                                                Pitcairn
                                        

                                                Poland
                                        

                                                Portugal
                                        

                                                Puerto Rico
                                        

                                                Qatar
                                        

                                                Reunion
                                        

                                                Romania
                                        

                                                Russia
                                        

                                                Rwanda
                                        

                                                S. Georgia and S. Sandwich Isls.
                                        

                                                Saint Kitts and Nevis
                                        

                                                Saint Lucia
                                        

                                                Saint Vincent and the Grenadines
                                        

                                                Samoa
                                        

                                                San Marino
                                        

                                                Sao Tome and Principe
                                        

                                                Saudi Arabia
                                        

                                                Senegal
                                        

                                                Serbia
                                        

                                                Seychelles
                                        

                                                Sierra Leone
                                        

                                                Singapore
                                        

                                                Slovak Republic
                                        

                                                Slovenia
                                        

                                                Solomon Islands
                                        

                                                Somalia
                                        

                                                South Africa
                                        

                                                South Korea
                                        

                                                South Sudan
                                        

                                                Spain
                                        

                                                Sri Lanka
                                        

                                                St. Helena
                                        

                                                St. Pierre and Miquelon
                                        

                                                Sudan
                                        

                                                Suriname
                                        

                                                Svalbard and Jan Mayen Islands
                                        

                                                Swaziland
                                        

                                                Sweden
                                        

                                                Switzerland
                                        

                                                Syria
                                        

                                                Taiwan
                                        

                                                Tajikistan
                                        

                                                Tanzania
                                        

                                                Thailand
                                        

                                                Togo
                                        

                                                Tokelau
                                        

                                                Tonga
                                        

                                                Trinidad and Tobago
                                        

                                                Tunisia
                                        

                                                Turkey
                                        

                                                Turkmenistan
                                        

                                                Turks and Caicos Islands
                                        

                                                Tuvalu
                                        

                                                US Minor Outlying Islands
                                        

                                                USSR (former)
                                        

                                                Uganda
                                        

                                                Ukraine
                                        

                                                United Arab Emirates
                                        

                                                United Kingdom
                                        

                                                United States
                                        

                                                Uruguay
                                        

                                                Uzbekistan
                                        

                                                Vanuatu
                                        

                                                Vatican City State (Holy See)
                                        

                                                Venezuela
                                        

                                                Vietnam
                                        

                                                Virgin Islands (British)
                                        

                                                Virgin Islands (U.S.)
                                        

                                                Wallis and Futuna Islands
                                        

                                                Western Sahara
                                        

                                                Yemen
                                        

                                                Yugoslavia
                                        

                                                Zaire
                                        

                                                Zambia
                                        

                                                Zimbabwe
                                        




Comments:





*Required Fields


 

 Submit








Already Registered?








Login attempt was not successful. Please try again








Username/ Email:



Password:





Enter Characters:















 

 Login





 Forget your password?
























By Job Title


Asset Managers |
                                    Corporate Banks |
                                    Investment Managers |
                                    Wealth Managers |
                                    Consultants & Advisors |
                                    Legal Practitioners |
                                    Academics |
                                    Hedge Funds |
                                    Private Equity Analysts |
                                    Traders |
                                    Equity Research Analysts


By Scope


Equity |
                                    Fixed Income |
                                    Funds |
                                    Excel  |
                                    Analytical Tools  |
                                    Markets  |
                                    Prices  |
                                    Money Market |
                                    News |
                                    Industry |
                                    IPOs |
                                    Mergers & Acquisitions |
                                    Commodities |
                                    Economics



Covered Countries and Exchanges

















Add Your Company | 
                                        Add Yourself | 
                                        Terms and Conditions | 
                                        Privacy Policy | 
                                        About DirectFN









Copyright ©  DirectFN. All Rights Reserved.











Data Not Available









Login











Login attempt was not successful. Please try again


Username/ Email:


Password:



Enter Characters:











 Forget your password?











Back to Top

Support & Feedback


Ask for free trial









Request a Trial
















Title:*


Mr
Mrs
Ms
Miss
Dr
Prof




First Name:*



Last Name:*



Email:*




Phone:*



Promo. Code:



Country:*


Select
Afganistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'Ivoire (Ivory Coast)
Croatia (Hrvatska)
Cuba
Curacao
Cyprus
Czech Republic
Czechoslovakia (former)
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia
New Zealand (Aotearoa)
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
S. Georgia and S. Sandwich Isls.
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
US Minor Outlying Islands
USSR (former)
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City State (Holy See)
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe




Company:*



Job Title:


Select
 Academics
 Asset Managers
 Consultants & Advisors
 Corporate Banks
 Equity Research Analysts
 Hedge Funds
 Investment Managers
 Legal Practioners
 Private Equity Analysts
 Traders
 Wealth Managers




Comments:




*Required Fields


 

 Submit



















Contact Us












Hello ,Please use the below form for
                            Product support & feedback


Name :  *  


Email:  * 


Phone Number :  * 






Preferred contact method :
Email
Phone











Technical Support 24x7: +94 112 314900 / slhops@directfn.net
Your Account Manager is, , , 






















 Get a Decypha Membership to view this content..................







Get a Decypha Membership


 Get the membership of Decypha Premium Package to access more exciting features including advanced analytical tools and the Pro 10 package. Pro 10 is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire.

All you need to access these valuable features is to click on the Get a membership button and submit your details to our sales team.















Upgrade your Membership


 Account is not entitled to view this information.

 Please contact your account manager to upgrade your Membership.

Email :  support@decypha.com






 Register to view this content..................







 Decypha Free Registration


Register free with Decypha and get access to real-time price information and many other features including Technical Scanner, Fundamental Screener etc.

Just click the Registration button, submit your details and get registered for free.








 




		The Company - Pluristem Therapeutics Inc.  Pluristem Therapeutics Inc.	

















































Pluristem Therapeutics Inc.







Company
Products 

PLX Products
Pipeline – PLX-PAD

Critical Limb Ischemia
Intermittent Claudication
Orthopedic Indications
Pulmonary Arterial Hypertension
Women’s Health


Pipeline – PLX-R18

Hematology
Acute Radiation Syndrome




Clinical Programs 

Clinical Development Strategy
Critical Limb Ischemia (CLI)
Intermittent Claudication (IC)
Muscle Injury
Acute Radiation Syndrome (ARS)
Hematopoietic cell Transplantation
Pulmonary Arterial Hypertension (PAH)


Science & Technology 

Mechanism of Action
3D Manufacturing Platform
Placenta
Intellectual Property
Additional Technologies
Preclinical Programs
Scientific Publications


Collaborations 

Partnering strategy
Industry Partners
Academic Partners


Investors & Media 

News
From the Media
Events
Presentations
Financial Statements
SEC Filing
Covering Analysts
Corporate Governance
IR Team























Pluristem Therapeutics Inc. is a clinical-stage biotherapy company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, ischemia, hematological disorders, or exposure to radiation.








Our vision
Our vision is to leverage our advanced technology and our position as a global leader in cell therapy to develop and manufacture highly effective cell products that will heal patients around the world.
Our strategy
Our strategy is to develop powerful cell therapies that can be successfully commercialized to reach patients who need innovative treatment options. We develop placenta-derived, “off-the-shelf” products that do not need genetic or tissue matching prior to administration and could be delivered in almost any clinical setting. We design distinct cell products to target a variety of indications, and anticipate that a pipeline of differentiated products and indications will allow us to target large global markets. We explore new partnerships to advance our clinical development programs, while maintaining our strong commitment to current corporate, academic and government collaborations.







Management Team
















Zami Aberman
Chairman & Co-CEO








Zami Aberman joined Pluristem in September 2005, and redirected the Company's strategy towards cellular therapeutics to become one of the global leaders in the industry. Mr. Aberman's vision to use the maternal portion of the placenta as a cell source for Pluristem’s products, combined with Pluristem's 3D culturing technology, led to the development of the Company's unique therapies. In 2013 the World Stem Cells Regenerative Medicine Congress ranked Mr. Aberman as one of the 50 most influential people in the stem cells space. Prior to Pluristem, Mr. Aberman had a 30 year career as a senior executive in the high-tech industry with multiple companies in Israel, the U.S., Europe, Japan and Korea. Previous roles include Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP; Director of Ori Software Ltd., a company involved in data management; President and CEO of Elbit Vision Systems (EVSNF.OB), which supplies inspection systems for the microelectronics industry; President and CEO of Netect Ltd., a company specializing in the field of internet security software; Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing; Chairman of Display Inspection Systems Inc., a company specializing in laser based inspection machines; and President and CEO of Robomatix Technologies Ltd. (RBMXF.OB). In addition to his current role at Pluristem, Mr. Aberman serves as the Chairman of Rose Hitech Ltd., a private investment company In 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.                                                












Yaky Yanay
Co-CEO and President








Yaky Yanay was appointed as our President from February 2014 and as our Co-CEO from March 2017. Mr. Yanay served as our Chief Financial Officer from November 2006 until February 2014 and from February 2015 until March 2017. He also served as our Chief Operating Officer from February 2014 until March 2017. Until February 2014, he also served as our Secretary since November 2006, and Executive Vice President since March 2013. Before joining Pluristem, Mr. Yanay was the Chief Financial Officer of Elbit Vision Systems Ltd., a public company. Prior to that Mr. Yanay served as manager of audit groups of the technology sector at Ernst & Young Israel. Mr. Yanay is Co-Chairman of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s high tech and life science industries. Yanay is representing Israel’s life sciences industry and has served on the Board of Directors of IATI for the past four years. Mr. Yanay also founded and served as Chairman of the “The Life Science Forum”. Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.                                                












Efrat Livne-Hadass
VP Human Resources








Efrat Livne-Hadass joined Pluristem in 2007 and is responsible for all aspects of Human Resources management, including recruitment, professional training, and well-being.
Prior to joining Pluristem and during the years 2001-2005, Ms. Livne-Hadass held the position of Human Resources Manager at Elbit Vision Systems, a company engaged in automatic optical inspection, located in Yokneam, Israel. While holding that position, she was involved in some major challenges and change processes which the company was going through, including managing HR in a small yet global public company.
Ms. Livne-Hadass holds an Executive M.A. for Human Resources managers from the department of Labor Studies, Tel-Aviv University and a B.Sw. degree from the Haifa University, majoring in public healthcare services.                                                












Hillit Mannor Shachar, M.D.
VP Business Development








Hillit Mannor Shachar, M.D., joined Pluristem in October 2013 as VP of Business Development. Prior to joining Pluristem, Dr. Shachar had over ten years' experience in both business development and corporate development having worked and consulted at companies including West Pharmaceutical Services, Nektar Therapeutics, Orex Computer Radiography (acquired by Kodak) and Transpharma Medical. Dr. Shachar worked at Apax Partners as a healthcare associate and at Deloitte Israel as a consultant in their life science practice.
Dr. Shachar graduated from Northwestern University's Honors Program in Medical Education and holds a B.A. and M.D. from there. In addition, she holds a M.B.A. from Kellogg Recanati Executive Program and an MSFS from Georgetown University.                                                












Erez Egozi
CFO








Mr. Erez Egozi was appointed Chief Financial Officer in March 2017, and as Secretary in September 2015. Prior to his appointment as CFO, Mr. Egozi was our Vice President of Finance from March 2015 until March 2017. Before Joining Pluristem, from 2007 to 2015, Mr. Egozi held several senior financial positions at Verint Systems Inc (Nasdaq:VRNT), including as senior director of finance - worldwide finance controller of Verint's Communications and Cyber Intelligence Solutions division. From 2003 to 2007, Mr. Egozi held several financial positions at Intel Corporation (Nasdaq:INTC). From 2000 to 2003, Mr Egozi served as an auditor in the high tech technology sector at Deloitte & Touche.  Mr. Egozi holds a bachelor's degree in economics and accounting from Beer-Sheva University, and a M.A. degree in law from Bar-Ilan University, and is a certified public accountant in Israel.                                                












Esther Lukasiewicz Hagai, M.D., Ph.D.
VP Clinical & Medical Affairs








Dr. Lukasiewicz-Hagai has twelve years' experience in Drug development. She joins Pluristem from Teva Global R&D, where she was Director, Clinical Program Leader, leading the global clinical development of multiple biosimilars and innovative drugs in various Oncologic and Neuropsychiatric indications. She previously worked at Gertner Institute for Epidemiology and Health Policy Research (Sheba Medical Center, Tel Hashomer) where she was responsible of multiple national and US-Israeli clinical trials in Orthopedic and Hemato-Oncologic indications. Dr Lukasiewicz-Hagai holds a M.D. and a Medical Residency in Public Health and Social Medicine from Necker-Enfants Malades Paris V School of Medicine In addition, she holds a Master of Methodology and Statistics in Clinical Research and a M. Med. Sc. in Biostatistics and Epidemiology from Paris XI as well as a Ph.D. in Biostatistics from Bar-Ilan University.                                                












Sagi Moran, M.B.A.
VP Operations








Sagi Moran, joined Pluristem in June 2014 as VP of Operations. Prior to joining Pluristem, Mr. Moran served as the CTO for LASER medical device startup AxonoGen Ltd., and as COO for NovoXel Ltd.
Mr. Moran established a medical division for Qualitest Group Ltd., the largest engineering and testing services group for the medical industry in Israel. The division provides services for pharmaceutical and medical companies, such as TEVA, PHILIPS healthcare, GE, UltraShape, Given Imaging and others. Prior to that Mr. Moran served for 10 years in Lumenis Ltd. In key global managerial position in R&D and Operations.
Mr. Moran holds a Master of Business Administration (MBA) from Recanati Executive MBA program at Tel-Aviv University, and a bachelor’s degree in Information Systems from Haifa University.                                                












Orly Amiran
VP Quality Assurance








Orly Amiran holds a master degree in Quality Assurance from the Technion and a B.Sc. in Pharmacy from the Hebrew University. She has worked in the pharmaceutical industry since 2001 and has extensive experience in Quality Assurance management in global companies which market drugs to the European market and to North America.
Prior to joining Pluristem Orly held the positions of Quality Assurance Manager at TEVA and Compliance Manager at Taro. She played a central role in successful regulatory agencies inspections in both positions.

Ms. Orly Amiran brings with her to Pluristem a vast experience and knowledge on GMP, quality regulations and the corresponding industry best practices.                                                












Racheli Ofir, Ph.D., MA. Law
VP Research & Intellectual Property








Racheli Ofir Joined Pluristem in 2007, serves as Vice President of research and intellectual property. The Research Department examines the various cells developed by the company, the properties of those cells and their mechanisms of action by using molecular methods and animal models to test the safety and efficacy. The IP department is responsible for intellectual property strategy development as well as the research that supports the IP.
Dr. Ofir is responsible for leading projects involving the characterization of PLX cells, Pluristem's leading placenta derived cell product candidate, including evaluating the biological activity of the cells in in-vitro and animal studies. She is responsible for the studies which determines the safety profile and pharmacokinetics of PLX cells. In addition, she is in charge of all pre-clinical aspects of the PLX regulatory process and for the communications with the relevant regulatory authorities (FDA, EMA and PEI).
Dr. Ofir is also responsible for applying and prosecuting over ten patent families filed worldwide, a co-inventor on five patent applications and the co-author of numerous peer reviewed articles.
Dr. Ofir earned her Ph.D. from the Technion, Israel institute of technology, where she investigated Telomeric position effects on gene expression and DNA replication in Human cells. She did her postdoctoral fellowship at the Technion in molecular embryology investigating genes involved in early development of vertebrates' nervous system.
Dr. Ofir has extensive research experience in molecular cell biology, embryology and cytogenetics as well as broad professional experience in the field of human cell therapy.                                                












Lior Raviv
VP Development








Lior Raviv joined Pluristem in 2011 and currently serves as Vice President of Development. Prior to that Mr. Raviv served as Process development engineer and Projects manager & Product development Team leader at Pluristem. Prior to joining Pluristem and during the years 2010-2011, Mr Raviv held the position of R&D Analytical Researcher at Teva Pharmaceutical Industries.
Mr. Raviv holds a M.Med.Sec in pharmacology from the Ben Gurion University and a B.S.c, in Biotechnology engineering from the Ben Gurion University.                                                












Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North America








Karine Kleinhaus, M.D., M.P.H., is Divisional Vice President, North America at Pluristem Therapeutics. She has worked with multiple public and private biotechnology companies, and prior to that she was an Assistant Professor in the Departments of Obstetrics and Gynecology and Psychiatry at the NYU School of Medicine. At NYU, Dr. Kleinhaus conducted medical research funded under a multi-year NIH grant. She published more than 25 papers in leading peer-reviewed journals such as the Annals of the New York Academy of Science, American Journal of Medical Genetics, and the American Journal of Epidemiology. Before that Dr. Kleinhaus practiced obstetrics and then completed two fellowships at Columbia University.
Dr. Kleinhaus received her medical degree from Tel Aviv University, earned a Master of Public Health from Columbia’s Mailman School of Public Health, and a bachelor’s degree, cum laude, from Princeton University.                                                












Board







Zami Aberman 






Mr. Zami Aberman joined Pluristem in September 2005, and redirected the Company's strategy towards cellular therapeutics to become one of the global leaders in the industry. Mr. Aberman's vision to use the maternal portion of the placenta as a cell source for Pluristem’s products, combined with Pluristem's 3D culturing technology, led to the development of the Company's unique therapies. In 2013 the World Stem Cells Regenerative Medicine Congress ranked Mr. Aberman as one of the 50 most influential people in the stem cells space. Prior to Pluristem, Mr. Aberman had a 30 year career as a senior executive in the high-tech industry with multiple companies in Israel, the U.S., Europe, Japan and Korea. Previous roles include Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP; Director of Ori Software Ltd., a company involved in data management; President and CEO of Elbit Vision Systems (EVSNF.OB), which supplies inspection systems for the microelectronics industry; President and CEO of Netect Ltd., a company specializing in the field of internet security software; Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing; Chairman of Display Inspection Systems Inc., a company specializing in laser based inspection machines; and President and CEO of Robomatix Technologies Ltd. (RBMXF.OB). In addition to his current role at Pluristem, Mr. Aberman serves as the Chairman of Rose Hitech Ltd., a private investment company In 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.													





Yaky Yanay 






Mr. Yaky Yanay was appointed as Pluristem’s President in February 2014 and as Co-CEO from March 2017. Mr. Yanay served as our Chief Financial Officer from November 2006 until February 2014 and from February 2015 until March 2017. He also served as our Chief Operating Officer from February 2014 until March 2017. Until February 2014, he also served as our Secretary since November 2006, and Executive Vice President since March 2013. Before joining Pluristem, Mr. Yanay was the Chief Financial Officer of Elbit Vision Systems Ltd., a public company. Prior to that Mr. Yanay served as manager of audit groups of the technology sector at Ernst & Young Israel. Mr. Yanay is Co-Chairman of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s high tech and life science industries. Yanay is representing Israel’s life sciences industry and has served on the Board of Directors of IATI for the past four years. Mr. Yanay also founded and served as Chairman of the “The Life Science Forum”. Mr. Yanay holds a bachelor’s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.													





Mark Germain 






Mr. Mark Germain has served as a Director on the Board of Directors since May 17, 2007. For more than the past five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries.
He has been involved as a founder, director, Chairman of the Board, and/or investor in over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions. He graduated New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law. From 1986 to 1991 he served in senior executive capacities, including as president of a public company that was sold in 1991, at which time he entered the biotech field.
In addition to being Co-Chairman at Pluristem, Mr. Germain is a director of the following publicly traded companies: Wellford Real Properties, Inc., Stem Cell Innovations, Inc., and Collexis Holdings, Inc. He is also a co-founder and director of a number of private companies in the biotechnology field.													





Hava Klemperer Meretzki 






Mrs. Hava Klemperer Meretzki, Adv. is a partner in the law firm of Ben-Noun Meretzki in Haifa, Israel. She specializes in civil, trade and labor law and is presently Vice-Chairman for the National Council of the Israel Bar Association. She previously was a Director of the Israel Electric Company. Ms. Meretzki received a Bachelors Degree in Law from the Hebrew University in 1991, and in 1992, was admitted to the Israel Bar Association.													





Doron Shorrer 






Mr. Doron Shorrer (CPA, Israel) was Chairman of the Board of Phoenix Insurance Company, one of the largest insurance companies in Israel and Mivtachim Pension Benefit Group, the largest pension fund in Israel, managing $15 billion. Before assuming these positions, Mr. Shorrer held senior appointments that included: Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the Board of Directors of "Nechasim" of the State of Israel; Member of the Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Co-Founder and Director of an accounting firm having three branches (Jerusalem, Tel-Aviv, Haifa); Member of the Lecture Staff of the Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy.
Among many areas of expertise, Mr. Shorrer formulates, implements and administers business planning in the private and institutional sector. Additionally, Mr. Shorrer consults on economic, accounting and taxation issues to a large audience, ranging from private concerns to government ministries. Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration, with a specialization in finance and banking from the Hebrew University of Jerusalem. He is a Certified Public Accountant (ISR).													





Isaac Braun 






Mr. Isaac Braun was appointed a Director of Pluristem on July 6, 2005. Mr. Braun is a business veteran with entrepreneurial, industrial and manufacturing experience. He has been a co-founder and board member of several hi-tech start-ups in the areas of e-commerce, security, messaging, search engines and biotechnology. Mr. Braun advises private companies on raising financing and business development.													





Israel Ben Yoram 






Mr. Israel Ben-Yoram was appointed a director of Pluristem on January 26, 2005. Mr. Ben-Yoram has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel from 1985 to the present. This accounting firm currently employs over 15 employees in the field of auditing, consulting, and associated projects. Since 1992, Mr. Ben-Yoram has served as a shareholder and the head director of Mor, Ben-Yoram Ltd., a private company in Israel, in parallel with the operation of the Mor, Ben-Yoram and Partners accounting firm. This company provides management services, economic consulting services and other professional services to businesses. Mr. Ben-Yoram received a B.A. in accounting from the University of Tel Aviv, an M.A. in Economics from the Hebrew University of Jerusalem, an L.L.B. and an M.B.A. from Tel Aviv University and an L.L.M. from Bar-Ilan University.													





Nachum Rosman 






Mr. Nachum Rosman is an expert in finance, management and organization. He has held Chief Executive and CFO positions in Israel, USA and England. He has operated in high-tech global companies in software and business. In these jobs he was responsible for finance management, fund-raising, acquisitions, technology sales, preparation of financial reports for due diligences, etc.
Mr. Rosman serves as a consultant to start-up companies in financing, strategy and reorganization. He serves as the CEO of Multiview Ltd, a company he co-founded in 1999. He serves as a director at Zoomix data mastering and Knolan.
Mr. Rosman was a director actively involved in the sale of New Dimension Ltd. to B.M.C. Inc. for $ 675 million. Prior to that he held a Co-CEO position in R.T.S. Ltd. (Virinet Ltd.), where he participated in the IPO on NASDAQ.													





Moria Kwiat 






Dr. Moria Kwiat is a Research Fellow in the Department of Materials and NanoSciences, Faculty of Chemistry at Tel Aviv University. During her studies she has gained a broad scientific experience in inter-disciplinary fields, and currently she is working on the development of a new generation of biosensors based on nano-materials. Mrs. Kwiat holds a B.Sc. and M.Sc. in Biotechnology from the Department of Molecular Microbiology and Biotechnology at Tel Aviv University, and a Ph.D. in Nano-Biotechnology from the Faculty of Exact Sciences at Tel Aviv University.													

















Pluristem Therapeutics Inc (PSTI.PH)  Company Profile | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Profile: Pluristem Therapeutics Inc (PSTI.PH)





Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				PSTI.PH on Philadelphia Stock Exchange


				1.21USD
20 Jul 2017





				    Change	(% chg)


		    
						    --


					            (--)
					        






Prev Close

$1.21


Open

--




Day's High

--


Day's Low

--




Volume

--


Avg. Vol

1,113




52-wk High

$1.80


52-wk Low

$1.06












					Full Description



Pluristem Therapeutics Inc., incorporated on May 10, 2001, is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. The Company's operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company's PLX products are administered using a standard needle and syringe. The Company's PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women's health diseases.The Company is investigating using PLX-PAD cells for treatments for various stages of peripheral arterial disease, from early-stage intermittent claudication (IC) to advanced CLI. As of June 30, 2016, the Company completed two Phase I safety/dose-finding clinical trials for CLI, one in the United States and one in Germany. The Company is conducting a Phase I/II, randomized, double-blind, placebo controlled study to assess the safety and efficacy of intramuscular injections of allogeneic PLX PAD cells for the regeneration of injured gluteal musculature after total hip replacement, in Germany. The Company focuses on pursuing the development of PLX-R18 in the treatment of recovery following Hematopoietic cell transplantation (HCT). As of June 30, 2016, the Company had conducted several in-vivo studies for the evaluation of PLX-R18 for the treatment of Acute Radiation Syndrome (ARS).The Company competes with Athersys, Inc., Capricor Therapeutics, Inc., Celgene Corporation, ReNeuron Group plc, Tigenix NV, SanBio Inc., Healios K.K., Cytori Therapeutics, Green Cross Cell Corp. and Mesoblast LTD.

» Full Overview of PSTI.PH







					Company Address



Pluristem Therapeutics Inc
Matam Advanced Technology ParkBuilding No. 5HAIFA      31905
P: +97274.7108600F: +97274.7108765







					Company Web Links



Home Page








					Officers & Directors






Name
Compensation




							 Yaky Yanay

786,721




							 Zalman Aberman

1,015,210




							 Erez Egozi

--




							 Doron Shorrer

--




							 Moria Kwiat

--




» More Officers & Directors





					Pluristem Therapeutics Inc News




BRIEF-Pluristem advances its limb ischemia study, targeting initiation at 40 active sites by the year end

Jul 10 2017 
BRIEF-Pluristem Therapeutics files for mixed shelf of up to $200 mln - SEC Filing

Jun 23 2017 
BRIEF-Innovation Medical Management scraps plan to invest in Israel's Pluristem Therapeutics

Jun 20 2017 
BRIEF-Pluristem provides shareholder update on corporate, clinical developments

May 22 2017 
BRIEF-Pluristem provides results from acute radiation syndrome preclinical study

May 03 2017 


» More PSTI.PH  News
















Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research




















